The global diphtheria vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Vaccination fosters to strengthen the immune system so that it can fight against specific antigen. Diphtheria vaccines are usually administered to prevent diphtheria, in infants that involve injection of antigens which are weaker version of target viruses. These antigens produce antibodies when body is exposed to similar kind of antigens, in future. This is one of easiest way to prepare the body to fight against the disease. Thus, the increasing preventive care among people is anticipated to drive the market growth. Most vaccines, including the diphtheria, pertussis, and tetanus (DPT) are given in the developing stage of the immune system. This factor is anticipated to drive the market growth.

Further, the global diphtheria vaccines market is projected to be propelled by the launch of combination vaccines recommended for vaccination programs to reduce the number of injections required while fulfilling vaccination compliance in infants. As mentioned above, DPT vaccines targets three diseases at once, namely, diphtheria, tetanus, and pertussis. Thus, the reduction of those doses into one as a part of combination vaccine is likely to offer immense growth opportunities for the market in the near future. As per the recommendations of Centers for Disease Control and Prevention (CDC), infants should be given three shots of DPT to build up high levels of protection against tetanus, whooping cough, and diphtheria. At the same time, young children should be given two booster shots to maintain that protection throughout their early childhood days. Rising initiatives by global organizations to promote vaccination programs, coupled with the growing awareness among the general public, is projected to drive the demand for these vaccines, thereby driving the global diphtheria vaccines market during the forecast period. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Johnson & Johnson Services, Inc., GlaxoSmithKline plc, and Merck & Co., Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Diphtheria Vaccine Market Report by Segment

By Type

    • DTaP

    • DT

    • Td

    • Tdap

By Application

    • Adolescents

    • Adults

    • Infants

    • Children

Global Diphtheria Vaccine Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa